Inhaled corticosteroids and risk of lower respiratory tract infection with


Journal

BMJ open respiratory research
ISSN: 2052-4439
Titre abrégé: BMJ Open Respir Res
Pays: England
ID NLM: 101638061

Informations de publication

Date de publication:
08 2023
Historique:
received: 25 03 2023
accepted: 28 07 2023
medline: 21 8 2023
pubmed: 20 8 2023
entrez: 19 8 2023
Statut: ppublish

Résumé

Use of inhaled corticosteroids (ICS) is common in patients with chronic obstructive pulmonary disease (COPD) and has been associated with an increased risk of pneumonia. To investigate if accumulated ICS use in patients with COPD, is associated with a dose-dependent risk of infection with This observational cohort study included 18 870 persons with COPD who were registered in The Danish Register of COPD. Linkage to several nationwide registries was performed.Exposure to ICS was determined by identifying all prescriptions for ICS, redeemed within 365 days prior to study entry. Main outcome was a lower respiratory tract sample positive for We found an increased, dose-dependent, risk of a lower respiratory tract sample with Our study shows a dose-dependent increased risk of infection with

Sections du résumé

BACKGROUND
Use of inhaled corticosteroids (ICS) is common in patients with chronic obstructive pulmonary disease (COPD) and has been associated with an increased risk of pneumonia.
OBJECTIVE
To investigate if accumulated ICS use in patients with COPD, is associated with a dose-dependent risk of infection with
METHODS
This observational cohort study included 18 870 persons with COPD who were registered in The Danish Register of COPD. Linkage to several nationwide registries was performed.Exposure to ICS was determined by identifying all prescriptions for ICS, redeemed within 365 days prior to study entry. Main outcome was a lower respiratory tract sample positive for
RESULTS
We found an increased, dose-dependent, risk of a lower respiratory tract sample with
CONCLUSION
Our study shows a dose-dependent increased risk of infection with

Identifiants

pubmed: 37597970
pii: 10/1/e001726
doi: 10.1136/bmjresp-2023-001726
pmc: PMC10441089
pii:
doi:

Substances chimiques

Adrenal Cortex Hormones 0

Types de publication

Observational Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: RBD reports having received payment for expert testimony. Remaining authors have no conflicts of interest.

Références

Respir Res. 2021 Jun 22;22(1):183
pubmed: 34154582
J Clin Med. 2022 Dec 23;12(1):
pubmed: 36614912
J Clin Med. 2022 Jun 20;11(12):
pubmed: 35743610
Biomedicines. 2021 Sep 24;9(10):
pubmed: 34680429
Vaccine. 2019 Sep 3;37(37):5551-5558
pubmed: 28185742
Clin Epidemiol. 2016 Oct 25;8:673-678
pubmed: 27822114
Eur Respir J. 2017 Oct 5;50(4):
pubmed: 28982774
Clin Microbiol Rev. 2002 Jan;15(1):125-44
pubmed: 11781271
Clin Epidemiol. 2012;4:303-13
pubmed: 23204870
Eur Respir Rev. 2021 Jun 23;30(160):
pubmed: 34168063
Am J Respir Crit Care Med. 2021 Mar 1;203(5):553-564
pubmed: 33252985
Infect Dis (Lond). 2022 Nov;54(11):784-793
pubmed: 35794793
Lancet Respir Med. 2016 May;4(5):390-8
pubmed: 27066739
Am J Respir Crit Care Med. 2020 Jun 15;201(12):1508-1516
pubmed: 32162970
Am J Respir Crit Care Med. 2005 Jul 15;172(2):195-9
pubmed: 15805178
Cochrane Database Syst Rev. 2012 Jul 11;(7):CD002991
pubmed: 22786484
Thorax. 2022 Jun;77(6):573-580
pubmed: 34446524
N Engl J Med. 2007 Feb 22;356(8):775-89
pubmed: 17314337
Cochrane Database Syst Rev. 2014 Mar 10;(3):CD010115
pubmed: 24615270
Stat Med. 2013 Aug 30;32(19):3388-414
pubmed: 23508673
Clin Chest Med. 2014 Mar;35(1):87-100
pubmed: 24507839
Scand J Public Health. 2011 Jul;39(7 Suppl):30-3
pubmed: 21775347
Ann Am Thorac Soc. 2014 Mar;11(3):303-9
pubmed: 24423399
Cochrane Database Syst Rev. 2013 Nov 10;(11):CD003794
pubmed: 24214176

Auteurs

Rikke Helin Johnsen (RH)

Section of Respiratory Medicine, Department of Medicine, Herlev-Gentofte Hospital, University of Copenhagen, Gentofte, Denmark.

Christian Kjer Heerfordt (CK)

Section of Respiratory Medicine, Department of Medicine, Herlev-Gentofte Hospital, University of Copenhagen, Gentofte, Denmark.

Jonas Bredtoft Boel (JB)

Department of Clinical Microbiology, Herlev-Gentofte Hospital, Herlev, Denmark.

Ram Benny Dessau (RB)

Department of Clinical Microbiology, Zealand University Hospital, University of Copenhagen, Slagelse, Denmark.
Department of Regional Health Research, University of Southern Denmark, Odense, Denmark.

Christian Ostergaard (C)

Department of Clinical Microbiology, Hvidovre Hospital, University of Copenhagen, Hvidovre, Denmark.

Pradeesh Sivapalan (P)

Section of Respiratory Medicine, Department of Medicine, Herlev-Gentofte Hospital, University of Copenhagen, Gentofte, Denmark.

Josefin Eklöf (J)

Section of Respiratory Medicine, Department of Medicine, Herlev-Gentofte Hospital, University of Copenhagen, Gentofte, Denmark.

Jens-Ulrik Stæhr Jensen (JS)

Section of Respiratory Medicine, Department of Medicine, Herlev-Gentofte Hospital, University of Copenhagen, Gentofte, Denmark jens.ulrik.jensen@regionh.dk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH